After sharp gains, API stocks are faced with few headwinds
Shares of active pharma ingredient (API) manufacturers may find the going choppy in the coming quarters. Investors are extrapolating the high growth rate of Q1 into the next year, which may not persist. No doubt, several API players saw a pick-up in revenues in Q1. However, the growth has been …
Read moreAfter sharp gains, API stocks are faced with few headwinds